LT175 is a novel PPARalpha/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties (Articolo in rivista)

Type
Label
  • LT175 is a novel PPARalpha/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties (Articolo in rivista) (literal)
Anno
  • 2014-01-01T00:00:00+01:00 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
  • 10.1074/jbc.M113.506394 (literal)
Alternative label
  • Gilardi, Federica; Giudici, Marco N.; Mitro, Nico; Maschi, Omar; Guerrini, Uliano; Rando, Gianpaolo; Maggi, Adriana C.; Cermenati, Gaia; Laghezza, Antonio; Loiodice, Fulvio; Pochetti, Giorgio; Lavecchia, Antonio; Caruso, Donatella; De Fabiani, Emma; Bamberg, Krister; Crestani, Maurizio (2014)
    LT175 is a novel PPARalpha/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties
    in The Journal of biological chemistry (Print)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Gilardi, Federica; Giudici, Marco N.; Mitro, Nico; Maschi, Omar; Guerrini, Uliano; Rando, Gianpaolo; Maggi, Adriana C.; Cermenati, Gaia; Laghezza, Antonio; Loiodice, Fulvio; Pochetti, Giorgio; Lavecchia, Antonio; Caruso, Donatella; De Fabiani, Emma; Bamberg, Krister; Crestani, Maurizio (literal)
Pagina inizio
  • 6908 (literal)
Pagina fine
  • 6920 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
  • http://www.scopus.com/record/display.url?eid=2-s2.0-84896780422&origin=inward (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 289 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 10 (literal)
Note
  • Scopu (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Universita degli Studi di Milano; Universita degli Studi di Bari; Consiglio Nazionale delle Ricerche; Universita degli Studi di Napoli Federico II; AstraZeneca Sweden; Universitat Lausanne Schweiz; Universite de Geneve (literal)
Titolo
  • LT175 is a novel PPARalpha/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties (literal)
Abstract
  • Background: PPARs are attractive targets of antidiabetic agents. However, PPAR ligands show side effects that hinder their clinical use. Results: LT175 improves insulin sensitivity and reduces body weight via selective gene activation in adipose tissue. Conclusion: LT175 shows an improved pharmacological profile linked to characteristic binding and differential coregulator recruitment. Significance: LT175 may be a scaffold molecule to design a safer generation of PPAR ligands. © 2014 by The American Society for Biochemistry and Molecular Biology, Inc. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it